Glenmark becomes fifth generic to be charged with US antitrust violations

Glenmark Pharmaceuticals has been charged with conspiring to fix prices for generic drugs, according to a statement released by the US Department of Justice.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

US states sue 26 drugmakers over alleged price fixing

11 June 2020 A coalition of attorneys general have taken 26 drugmakers, including Pfizer, Sandoz and Mylan, to court over the alleged price-fixing of topical generic drugs.

Generics

Teva charged in DoJ antitrust probe into generic drug price-fixing

26 August 2020 Teva Pharmaceuticals has been charged with conspiring to fix prices, rig bids, and allocate customers for generic drugs, the US Department of Justice has announced.

Americas

MSD and Glenmark appeal pay-for-delay Zetia dispute

7 January 2021 Pharmaceutical companies MSD and Glenmark have argued that the class certification of wholesale buyers of cholesterol drug Zetia should be reversed because the circumstances of the class members do not justify an award of class status.

More on this story

Americas

US states sue 26 drugmakers over alleged price fixing

11 June 2020 A coalition of attorneys general have taken 26 drugmakers, including Pfizer, Sandoz and Mylan, to court over the alleged price-fixing of topical generic drugs.

Generics

Teva charged in DoJ antitrust probe into generic drug price-fixing

26 August 2020 Teva Pharmaceuticals has been charged with conspiring to fix prices, rig bids, and allocate customers for generic drugs, the US Department of Justice has announced.

Americas

MSD and Glenmark appeal pay-for-delay Zetia dispute

More on this story

Americas

US states sue 26 drugmakers over alleged price fixing

11 June 2020 A coalition of attorneys general have taken 26 drugmakers, including Pfizer, Sandoz and Mylan, to court over the alleged price-fixing of topical generic drugs.

Generics

Teva charged in DoJ antitrust probe into generic drug price-fixing

26 August 2020 Teva Pharmaceuticals has been charged with conspiring to fix prices, rig bids, and allocate customers for generic drugs, the US Department of Justice has announced.

Americas

MSD and Glenmark appeal pay-for-delay Zetia dispute